Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *